Insulin glulisine Subcutaneous and Noxafil (Posaconazole Delayed-Release Tablets)
Determining the interaction of Insulin glulisine Subcutaneous and Noxafil (Posaconazole Delayed-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Noxafil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine Subcutaneous-Noxafil (Posaconazole Injection)
- Insulin glulisine Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- Insulin glulisine Subcutaneous-Noxafil Intravenous
- Insulin glulisine Subcutaneous-Noxifol-D
- Insulin glulisine Subcutaneous-Noxivent
- Insulin glulisine Subcutaneous-NP Thyroid
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin human inhaled Inhalation
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin human regular Injection
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin inhalation
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin isophane
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin isophane and insulin regular
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin lispro